We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Sepsis Test Delivers Two Days Faster Results

By LabMedica International staff writers
Posted on 19 Feb 2024

In 2017, around 49 million sepsis cases and 11 million sepsis-related deaths were reported globally, as highlighted in a study by the WHO. More...

This staggering figure represents 20% of all deaths worldwide. In such critical cases, speed and accuracy in identifying the bacteria in a patient's bloodstream are vital. This enables doctors to administer the correct antibiotics swiftly, halting the infection's progression. Researchers have now achieved a diagnostic breakthrough after testing a new way to analyze blood samples for suspected sepsis that provided test results two days earlier than before.

Doctors at The Helgeland Hospital Trust (Nordland, Norway), in collaboration with other researchers, explored a novel analysis method known as BCID2. Initially used in several smaller hospitals for analyzing COVID-19 tests during the pandemic, its application for rapid sepsis analysis in Norway had not been explored until now. Their primary objective was to ascertain if this rapid method could be just as effective in smaller hospitals as the traditional, more time-consuming analysis conducted in larger hospital labs. This would mark a significant advancement in the treatment of suspected sepsis patients at local hospitals, particularly crucial for smaller facilities located far from major labs.

The study involved analyzing 160 blood samples containing bacteria, collected from a hospital between July and December 2021. While rapid tests were conducted at various local hospitals, standard tests were carried out in a microbiological lab at a regional hospital. The results were promising: the Helgeland doctors received test outcomes two days earlier than before, with accuracy nearly matching that of tests performed at the larger lab using traditional bacterial culturing methods. The BCID2 method also indicated better antibiotic treatment options in one out of four cases. There were fewer than 3% instances where the new test failed to identify bacteria present in the blood. Importantly, there were no false positives – cases where the rapid test incorrectly indicated bacterial presence in the blood.

“The conclusion is that this is a robust and accurate addition to traditional diagnostics for detecting bacteria in blood samples quickly. The method offers great potential for more targeted antibiotic use at local hospitals”, said Kristoffer Hammer Endresen from Nordland Hospital Trust.

“This is an innovative solution with great potential for better treatment and equitable services at local hospitals,” added Hege Harboe-Sjåvik at the Helgeland Hospital Trust. “Two days faster test results can have a significant impact on seriously ill patients at local hospitals. This can provide a more equitable patient service, without the need for patients or healthcare personnel to be moved between hospitals.”

Related Links:
The Helgeland Hospital Trust


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemodynamic System Monitor
OptoMonitor
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.